Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

The Economic Burden of Inflammatory Heart Disease in Korea

  • Ko, Seul-Ki (School of Medicine, Korea University) ;
  • Yoon, Seok-Jun (Department of Preventive Medicine, College of Medicine, Korea University) ;
  • Oh, In-Hwan (Department of Preventive Medicine, College of Medicine, Korea University) ;
  • Seo, Hye-Young (Department of Public Health, Graduate School of Korea University) ;
  • Kim, Eun-Jung (Department of Nursing, Cheju Halla College)
  • Published : 2011.12.30
⟨ Previous Next ⟩

Abstract

Background and Objectives: The incidence of inflammatory heart diseases is not yet as high as those of other cardiovascular diseases; however, inflammatory heart diseases do have relatively high mortality rate. Therefore, update information on the economic burden of inflammatory heart diseases are necessary in order to appropriate policy making on these diseases. Materials and Methods: This study used a number of resources to obtain data, national health insurance statistics, the Korean Health Panel, and the causes of death report by the Korean National Statistical Office. The total costs of inflammatory heart diseases were estimated as the sum of direct medical care costs, direct non-medical care and indirect costs. Results: The total direct cost of inflammatory heart disease was higher in Korean men than that of Korean women and cost due to inpatient was higher than that of outpatients cost. The costs to cover premature death were highest among all of the components used to determine the total costs for inflammatory heart disease, representing 66.3% of these costs in Korea. Conclusion: Inflammatory heart disease has a relatively high mortality rate, and the costs that are associated with premature deaths consume the greatest proportion of the costs associated with this disease. In spite of some limitations of study, this could be a reliable evidence of economic burden of inflammatory heart disease.

Keywords

References

  1. Fairweather D, Rose NR. Inflammatory heart disease: a role for cytokines. Lupus 2005;14:646-51. https://doi.org/10.1191/0961203305lu2192oa
  2. World Health Organization. The global burden of disease: 2004 update [Internet]. Geneva: World Health Organization [cited 2009 Feb 20]. Available from: http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index.html.
  3. Hufnagel G, Pankuweit S, Richter A, Schonian U, Maisch B. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID)-first epidemiological results. Herz 2000;25:279-85. https://doi.org/10.1007/s000590050021
  4. Dec GW. Introduction to clinical myocarditis. In: Cooper LT, editor. Myocarditis: from bench to bedside. New Jersey: Human Press;2003. p.257-81.
  5. Drory Y, Turetz Y, Hiss Y, et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991;68:1388-92. https://doi.org/10.1016/0002-9149(91)90251-F
  6. Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis 2010;52:274-88. https://doi.org/10.1016/j.pcad.2009.11.006
  7. Jung YH, Ko SJ. Estimating socioeconomic costs of five major diseases. J Korean Assoc Public Finance 2004;18:77-104.
  8. Kim SY, Yoon SJ, Jo MW, Kim EJ, Kim HJ, Oh IH. Economic burden of allergic rhinitis in Korea. Am J Rhinol Allergy 2010;24:e110-3.
  9. Mathers CD, Vos T, Lopez AD, Salomon J, Ezzati M. National Burden of Disease Studies: a Practical Guide. 2nd ed. Geneva: World Health Organization;2001.
  10. National Health Insurance Corporation. National Health Insurance Statistical Yearbook. Seoul: National Health Insurance Corp;2007. p.488-9.
  11. Park BH, Lee TJ, Lim WY. Incidence and magnitude of out-of-pocket payment and factors influencing them in Industrial Accident Compensation Insurance. Korean Journal of Health Policy and Administration 2010;20:103-24. https://doi.org/10.4332/KJHPA.2010.20.1.103
  12. Kim JH, Jung JC, Lee HY, Choi SJ, Lee JK. Results of survey on medical care cost by patient. In: Survey on the Benefit Coverage Rate of National Health Insurance in 2005. Seoul: National Health Insurance Corp;2006. p.131-8.
  13. Yoon SJ, Kim EJ, Kim HJ, Oh Ih, Seo HY. A study on measuring the economic burden of cardio-cerebrovasucular disease in Korea. Seoul: Korea Centers for Disease Control and Prevention;2011.
  14. Korea Institute for Health and Social Affairs and National Health Insurance Corporation. Korea Health Panel [Internet]. Seoul: Korea Institute for Health and Social Affairs and National Health Insurance corporation [Cited 2011 Jan 4] Available from: http://www.khp.re.kr.
  15. Survey Report on Wage Structure in 2008. Ministry of Labor[Internet]. Ministry of Labor [cited 2011 Jan 4]. Available from: http://www.laborstat molab.go.kr.
  16. National Statistical Office. The Cause of Death Statistics of 2008. Seoul;2009.
  17. Kim J, Hahm MI, Park EC, et al. Economic burden of cancer in South Korea for the year 2005. J Prev Med Public Health 2009;42:190-8. https://doi.org/10.3961/jpmph.2009.42.3.190
  18. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-20. https://doi.org/10.1001/jama.287.10.1308
  19. World Heart Federation: different heart diseases [Internet]. Geneva: World Heart Federation [cited 2011 Jan 4]. Available from: http://www.worldheart.org.
  20. Ariza MA, Vimalananda VG, Rosenzweig JL. The economic consequences of diabetes and cardiovascular disease in the United States. Rev Endoc Metab Disord 2010;11:1-10. https://doi.org/10.1007/s11154-010-9128-2